GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Merdury Biopharmaceutical 6932.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

5.23

+1.75%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Merdury Biopharmaceutical annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In TWD.

FY2025FY2024FY2023FY2022FY2021
Revenue—TWD 5.0mTWD 1.0mTWD 2.7m—
Operating income−TWD 68.5m−TWD 54.0m−TWD 43.1m−TWD 30.9m−TWD 5.3m
Net income−TWD 67.2m−TWD 50.6m−TWD 43.8m−TWD 31.3m−TWD 5.3m
Free cash flow−TWD 58.1m−TWD 45.8m−TWD 55.7m−TWD 94.5m−TWD 12.3m
Total assetsTWD 278.4mTWD 353.2mTWD 438.1mTWD 229.9mTWD 13.4m
Shareholders' equityTWD 219.7mTWD 290.3mTWD 388.4mTWD 180.3mTWD 10.5m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.